Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000942794-99-000006
Filing Date
1999-03-23
Accepted
1999-03-23 00:00:00
Documents
5
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 10-K405 167744
2 EX-4 53050
3 EX-11 2279
4 EX-23 832
5 EX-27 2374
  Complete submission text file 0000942794-99-000006.txt   228169
Mailing Address 365 PLANTATION STREET WORCESTER MA 01605
Business Address 175 CROSSING BLVD BIOTECHNOLOGY RESEARCH PARK FRAMINGHAM MA 01605 5087975777
AQUILA BIOPHARMACEUTICALS INC (Filer) CIK: 0000704292 (see all company filings)

EIN.: 043307818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-12081 | Film No.: 99570848
SIC: 2835 In Vitro & In Vivo Diagnostic Substances